Công bố thông tin - Imexpharm - Page 12

Information Disclosure

IMP: Resolution of the BOD No.06/2023/NQ-HĐQT-IMP dated July 10, 2023

07/11/2023

IMP - Information disclosure: No. 317 Announcement of audit contract in 2023

07/11/2023

IMP - Information on the number of members nominated and running for the position of member of the BOD of IMP for the 2023-2027 term

05/15/2023

IMP - Information disclosure: Internal regulations on corporate governance approved by the AGM on April 28, 2023

04/29/2023

IMP - Resolution of the BOD at the 1st meeting for the term of 2023-2027

04/29/2023

IMP - Information disclosure: Charter approved by the AGM on April 28, 2023

04/29/2023

IMP - Information disclosure: Operating regulations of the BOD approved by the AGM on April 28, 2023

04/29/2023

IMP - Information disclosure: Personnel changes April 28, 2023

04/29/2023

IMP - Information Disclosure: No. 191- Proposal No. 13/2023/TTr-HĐQT dated April 18, 2023

04/18/2023

IMP - Resolutions of the BOD No. 04/2023/NQ-HĐQT-IMP dated April 14, 2023

04/14/2023